Staged Versus Complete Repair in the Symptomatic Neonate With Tetralogy of Fallot.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
03 2020
Historique:
received: 08 05 2019
revised: 08 09 2019
accepted: 02 10 2019
pubmed: 30 11 2019
medline: 8 5 2020
entrez: 30 11 2019
Statut: ppublish

Résumé

The optimal management of tetralogy of Fallot (TOF) in symptomatic neonates remains unknown. We compared outcomes for those undergoing palliation vs complete repair in the neonatal period. In a retrospective cohort study of symptomatic neonates with TOF who had a neonatal complete repair (group 1, n = 112) or staged repair (group 2, n = 26) from 2000 to 2013, we compared outcomes at 4 time points: neonatal complete repair vs palliation (group 1 vs 2A), neonatal vs later complete repair (group 1 vs 2B), the single vs combined admissions to achieve a complete repair (group 1 vs group 2A + 2B), and cumulative events 2 years after complete repair for both groups. Demographics, anatomy, comorbidities, surgical approach, and mortality were similar between groups 1 and 2. Group 1 had a longer duration of cardiopulmonary bypass and deep hypothermic circulatory arrest and more postprocedure cardiac events compared with group 2A; a longer duration of intubation, intensive care, and postprocedure hospital stay compared with groups 2A and 2B; and a longer total hospital stay compared with group 2B. With combined admissions for group 2, there was no difference in the total duration of intensive care, total hospital stay, or reinterventions compared with group 1. Both management options result in similar survival; however, early morbidity was greater with neonatal complete repair. The impact of increased neonatal exposures, such as cardiopulmonary bypass, deep hypothermic circulatory arrest, and intensive care, on neurocognitive development requires further study but should be considered when choosing an optimal strategy.

Sections du résumé

BACKGROUND
The optimal management of tetralogy of Fallot (TOF) in symptomatic neonates remains unknown. We compared outcomes for those undergoing palliation vs complete repair in the neonatal period.
METHODS
In a retrospective cohort study of symptomatic neonates with TOF who had a neonatal complete repair (group 1, n = 112) or staged repair (group 2, n = 26) from 2000 to 2013, we compared outcomes at 4 time points: neonatal complete repair vs palliation (group 1 vs 2A), neonatal vs later complete repair (group 1 vs 2B), the single vs combined admissions to achieve a complete repair (group 1 vs group 2A + 2B), and cumulative events 2 years after complete repair for both groups.
RESULTS
Demographics, anatomy, comorbidities, surgical approach, and mortality were similar between groups 1 and 2. Group 1 had a longer duration of cardiopulmonary bypass and deep hypothermic circulatory arrest and more postprocedure cardiac events compared with group 2A; a longer duration of intubation, intensive care, and postprocedure hospital stay compared with groups 2A and 2B; and a longer total hospital stay compared with group 2B. With combined admissions for group 2, there was no difference in the total duration of intensive care, total hospital stay, or reinterventions compared with group 1.
CONCLUSIONS
Both management options result in similar survival; however, early morbidity was greater with neonatal complete repair. The impact of increased neonatal exposures, such as cardiopulmonary bypass, deep hypothermic circulatory arrest, and intensive care, on neurocognitive development requires further study but should be considered when choosing an optimal strategy.

Identifiants

pubmed: 31783017
pii: S0003-4975(19)31745-X
doi: 10.1016/j.athoracsur.2019.10.013
pmc: PMC7054157
mid: NIHMS1544563
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

802-808

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL125521
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Références

Ann Thorac Surg. 2010 Sep;90(3):813-9; discussion 819-20
pubmed: 20732501
Circulation. 1995 Mar 1;91(5):1506-11
pubmed: 7532554
Eur J Cardiothorac Surg. 2000 Jun;17(6):631-6
pubmed: 10856851
Ann Thorac Surg. 2001 May;71(5):1556-61; discussion 1561-3
pubmed: 11383800
Ann Thorac Surg. 1992 Nov;54(5):903-7
pubmed: 1417283
Korean J Pediatr. 2014 Jan;57(1):19-25
pubmed: 24578712
Ann Surg. 2000 Oct;232(4):508-14
pubmed: 10998649
J Thorac Cardiovasc Surg. 2017 Nov;154(5):1692-1700.e2
pubmed: 28666664
Ann Thorac Surg. 2010 Mar;89(3):858-63
pubmed: 20172143
J Thorac Cardiovasc Surg. 2004 Mar;127(3):692-704
pubmed: 15001897
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2642-7
pubmed: 25156467
J Thorac Cardiovasc Surg. 2014 Apr;147(4):1299-305
pubmed: 23879934
Circulation. 2000 Nov 7;102(19 Suppl 3):III123-9
pubmed: 11082374
Eur J Cardiothorac Surg. 2005 Sep;28(3):394-9
pubmed: 15975817
Eur J Cardiothorac Surg. 2006 Dec;30(6):917-22
pubmed: 17052914
Ann Thorac Surg. 2003 Feb;75(2):S729-34
pubmed: 12607719
J Thorac Cardiovasc Surg. 2003 Sep;126(3):703-10
pubmed: 14502142
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;7:125-32
pubmed: 15283362
J Thorac Cardiovasc Surg. 1995 Feb;109(2):332-42, 344; discussion 342-3
pubmed: 7531798
Ann Thorac Surg. 2006 Jun;81(6):S2381-8
pubmed: 16731107
Ann Thorac Surg. 2016 Sep;102(3):850-858
pubmed: 27173073
Ann Thorac Surg. 2010 Apr;89(4):1255-9
pubmed: 20338347
J Thorac Cardiovasc Surg. 2004 May;127(5):1256-61
pubmed: 15115980
Heart Lung Circ. 2009 Aug;18(4):271-6
pubmed: 19162543
Ann Thorac Surg. 2008 Dec;86(6):1928-35
pubmed: 19022010
Ann Thorac Surg. 2005 Oct;80(4):1431-8; discussion 1438-9
pubmed: 16181883

Auteurs

Jennifer Bailey (J)

Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Okan U Elci (OU)

Biostatistics and Data Management Core-Westat, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Christopher E Mascio (CE)

Division of Cardiothoracic Surgery, Department of Surgery, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Laura Mercer-Rosa (L)

Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Elizabeth Goldmuntz (E)

Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: goldmuntz@email.chop.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH